Skip to search formSkip to main contentSkip to account menu

moexipril

Known as: 2-((1-ethoxycarbony)-3-phenylpropylamino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, Moexiprilum, moexipril [Chemical/Ingredient] 
A non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, moexipril is hydrolyzed into its active… 
National Institutes of Health

Related topics

Related topics

18 relations
AngioedemaAngiotensin-Converting Enzyme Inhibitors [MoA]Congestive heart failureDecreased Blood Pressure [PE]

Broader (3)

Angiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsTetrahydroisoquinolines

Narrower (4)

FempressMoexipril hydrochlorideRS 10085Univasc

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors
The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of essential hypertension, stable chronic… 
Review
2001
Review
2001
Chemical reactivity in solid-state pharmaceuticals: formulation implications.
1998
1998
Moexipril
SummarySynopsisMoexipril is aprodrug which is hydrolysed after oral administration to its active metabolite moexiprilat, an… 
Review
1998
Review
1998
Pharmacologic, Pharmacokinetic, and Therapeutic Differences among ACE Inhibitors
Angiotensin‐converting enzyme (ACE) inhibitors are a heterogeneous group of agents, and important pharmacologic, pharmacokinetic… 
Highly Cited
1998
Highly Cited
1998
Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and AT II receptor antagonists.
A gas chromatography-mass spectrometry (GC-MS) screening procedure was developed for the detection of angiotensin-converting… 
Review
1998
Review
1998
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
We review studies that have examined the relationship between magnetic resonance imaging findings and clinical disability… 
Highly Cited
1996
Highly Cited
1996
Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
1995
1995
Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17β-estradiol and their combination on the ovariectomy‐induced…
Objective No data are available on whether angiotensin converting enzyme (ACE) inhibition affects the skeleton, though this might… 
1995
1995
THE ANTIHYPERTENSIVE PROPERTIES OF THE ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR MOEXIPRIL GIVEN ALONE OR IN COMBINATION WITH A LOW DOSE OF A DIURETIC
The antihypertensive characteristics of the angiotensin-converting enzyme inhibitor moexipril were evaluated in 413 patients with… 
Highly Cited
1994
Highly Cited
1994
Angiotensin-Converting Enzyme Inhibition in Infarct-Induced Heart Failure in Rats: Bradykinin Versus Angiotensin II
Background: The beneficial effects of angiotensin-converting enzyme (ACE) inhibitors in the prevention of heart failure following… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)